Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms-Reference-Cited by-同舟云学术

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms

Published:2023-09 Issue: Volume:95 Page:104752
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Ariey-Bonnet Jérémy^ORCID,Berges Raphael,Montero Marie-Pierre,Mouysset Baptiste,Piris Patricia,Muller Kevin,Pinna Guillaume,Failes Tim W.,Arndt Greg M.,Morando Philippe,Baeza-Kallee Nathalie,Colin Carole,Chinot Olivier,Braguer Diane,Morelli Xavier,André Nicolas,Carré Manon,Tabouret Emeline,Figarella-Branger Dominique,Le Grand Marion^ORCID,Pasquier Eddy^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference66 articles.

1. Precision oncology in the age of integrative genomics;Kumar-Sinha;Nat Biotechnol,2018

2. Maximizing the utility of cancer transcriptomic data;Xiang;Trends Cancer,2018

3. Network pharmacology: the next paradigm in drug discovery;Hopkins;Nat Chem Biol,2008

4. Combinatorial drug therapy for cancer in the post-genomic era;Al-Lazikani;Nat Biotechnol,2012

5. Polypharmacology - foe or friend?;Peters;J Med Chem,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP inhibition enhances exemestane efficacy in triple-negative breast cancer;2024-07-31

2. A Synopsis of Biomarkers in Glioblastoma: Past and Present;Current Issues in Molecular Biology;2024-07-03

3. Aurora kinase A inhibition plus Tumor Treating Fields suppress glioma cell proliferation in a cilium-independent manner;Translational Oncology;2024-07

4. Preclinical Evaluation of JAB-2485, a Potent AURKA Inhibitor with High Selectivity and Favorable Pharmacokinetic Properties;ACS Omega;2024-05-03

5. The Roles of AGTRAP, ALKBH3, DIVERSIN, NEDD8 and RRM1 in Glioblastoma Pathophysiology and Prognosis;Biomedicines;2024-04-22